Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Accenture
Mallinckrodt
Federal Trade Commission
Cerilliant
Merck
Citi
Cipla
McKinsey

Generated: June 24, 2018

DrugPatentWatch Database Preview

AUGMENTIN XR Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Augmentin Xr patents expire, and when can generic versions of Augmentin Xr launch?

Augmentin Xr is a drug marketed by Dr Reddys Labs Inc and is included in one NDA. There are five patents protecting this drug and one Paragraph IV challenge.

This drug has ninety-six patent family members in forty-eight countries.

The generic ingredient in AUGMENTIN XR is amoxicillin; clavulanate potassium. There are forty-five drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the amoxicillin; clavulanate potassium profile page.
Summary for AUGMENTIN XR
Drug patent expirations by year for AUGMENTIN XR
Pharmacology for AUGMENTIN XR
Synonyms for AUGMENTIN XR
2C16H19N3O5S.C8H8NO5.K
4-Oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, monopotassium salt, (2R-(2-alpha,3Z,5-alpha))-, mixt. with (2S-(2-alpha,5-alpha,6-beta(S*)))-6-((amino(4-hydroxyphenyl)acetyl)amino)-3,3-dime
4-Oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, monopotassium salt, (2R,3Z,5R)-, mixt. with (2S,5R,6R)-6-(((2R)-amino(4-hydroxyphenyl)acetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.
4-Oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-,monopotassium salt, (2R-(2-alpha,3Z,5-alpha))-, mixt. with (2S-(2-alpha,5-alpha,6-beta(S*)))-6-((amino(4-hydroxyphenyl)acetyl)amino)-3,3-dimet
74428-36-7
74469-00-4
79198-29-1 (parent)
Amocla
Amoclan
Amoclav
Amoxi-Clavulanate
Amoxicillin / clavulanic acid
Amoxicillin clavulanate potassium
Amoxicillin mixed with potassium clavulanate (2:1)
Amoxicillin mixture with Clavulanate potassium
Amoxicillin-Clavulanic Acid
Amoxicillin-potassium clavulanate combination
AMOXICILLIN; CLAVULANATE POTASSIUM
Amoxsiklav
Amoxycillin-Clavulanic Acid
Ancla
Augmentan
AUGMENTIN '250'
Augmentin (antibiotic)
Augmentine
Auspilic
BRL 25000
BRL 25000A
BRL 25000G
BRL-25000
CHEMBL1697738
Clamentin
Clamobit
Clavam 625
Clavamox
Clavinex
Clavoxilin Plus
Clavulanate Potentiated Amoxycillin
Clavulin
Clavumox
Co-amoxiclav
Coamoxiclav
DTXSID40225477
DWHGNUUWCJZQHO-ZVDZYBSKSA-M
Eumetinex
HE385305
Kmoxilin
LS-187831
LS-98547
Potassium clavulanate mixed with amoxicillin (1:2)
Potassium Clavulanate-Amoxicillin Combination
SCHEMBL240728
Spectramox
Spektramox
Viaclav
Xiclav

US Patents and Regulatory Information for AUGMENTIN XR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Inc AUGMENTIN XR amoxicillin; clavulanate potassium TABLET, EXTENDED RELEASE;ORAL 050785-001 Sep 25, 2002 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Dr Reddys Labs Inc AUGMENTIN XR amoxicillin; clavulanate potassium TABLET, EXTENDED RELEASE;ORAL 050785-001 Sep 25, 2002 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Dr Reddys Labs Inc AUGMENTIN XR amoxicillin; clavulanate potassium TABLET, EXTENDED RELEASE;ORAL 050785-001 Sep 25, 2002 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Dr Reddys Labs Inc AUGMENTIN XR amoxicillin; clavulanate potassium TABLET, EXTENDED RELEASE;ORAL 050785-001 Sep 25, 2002 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Paragraph IV (Patent) Challenges for AUGMENTIN XR
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Extended-release Tablets 1000 mg/62.5 mg ➤ Subscribe 2009-01-21

Non-Orange Book US Patents for AUGMENTIN XR

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,294,199 Method of treating a bacterial infection comprising administering amoxycillin ➤ Try a Free Trial
6,660,299 Modified release pharmaceutical formulation comprising amoxycillin ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Accenture
Fuji
McKesson
Citi
UBS
Moodys
Express Scripts
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.